Sanofi Stock Forecast

Stock Price Forecast

According to 24 analysts polled by S&P Global, Sanofi stock has a consensus rating of "Buy" and an average price target of €94.28. The average 1-year stock price forecast is 21.20% higher than the current stock price, while the lowest is €78.00 (+0.27%) and the highest is €112.00 (+43.98%).

Price Target: €94.28 (+21.20%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	€78.00	€94.28	€95.00	€112.00
Change	+0.27%	+21.20%	+22.12%	+43.98%

Analyst Ratings

The average analyst rating for Sanofi stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	10	10	10	10	10	10
Buy	4	3	2	1	2	2
Hold	10	11	12	12	12	12
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	24	24	24	23	24	24

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sarita Kapila Morgan Stanley	Morgan Stanley	Hold Maintains €86.00 → €82.00	Hold	Maintains	€86.00 → €82.00	+5.41%	Aug 11, 2026
Michael Leuchten Jefferies	Jefferies	Buy Maintains €100.00	Buy	Maintains	€100.00	+28.55%	Aug 7, 2026
Justin Smith Bernstein	Bernstein	Buy Maintains €107.00 → €106.21	Buy	Maintains	€107.00 → €106.21	+36.53%	Aug 4, 2026
Luisa Hector Berenberg Bank	Berenberg Bank	Buy Maintains €105.00	Buy	Maintains	€105.00	+34.98%	Aug 3, 2026
Matthew Weston UBS	UBS	Hold Maintains €88.00 → €78.00	Hold	Maintains	€88.00 → €78.00	+0.27%	Jul 31, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

47.59B

from 46.72B

1.88%

from 46.72B

Revenue Next Year

50.70B

from 47.59B

6.54%

from 47.59B

EPS This Year

8.59

from 7.83

9.67%

from 7.83

EPS Next Year

9.07

from 8.59

5.59%

from 8.59

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	39.18B	40.30B	41.11B	44.29B	46.72B	47.59B
Revenue Growth	4.83%	2.88%	2.00%	7.73%	5.49%	1.88%
Gross Profit	26.92B	28.44B	28.49B	31.09B	33.79B	36.25B
Gross Margin	68.73%	70.55%	69.30%	70.21%	72.34%	76.16%
Operating Income	8.57B	10.38B	8.12B	8.87B	9.65B	13.25B
Net Income	6.22B	8.37B	5.40B	5.56B	7.81B	7.94B
EPS	-	-	-	-	7.83	8.59
EPS Growth	-	-	-	-	9.97%	9.67%
Forward PE	12.54	10.60	11.13	11.50	10.03	9.06
Dividend / Share	3.33	3.56	3.76	3.92	4.12	4.25
Dividend Growth	4.06%	6.91%	5.62%	4.26%	5.10%	3.26%
Free Cash Flow	7.34B	8.51B	7.17B	-4.94B	16.64B	8.34B
No. Analysts	-	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	48.1B
Avg	47.6B
Low	46.3B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	3.1%
Avg	1.9%
Low	-0.8%

EPS Forecast

Chart

EPS	2026	2027	2028
High	8.96
Avg	8.59
Low	8.09

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	14.4%
Avg	9.7%
Low	3.3%